I

Instituto Nacional de Pediatria | Clinical Research Support Unit | Mexico City, United States

Research site
(Unclaimed)
Location
Insurgentes Sur 3700-C, Mexico City, Ciudad de Mexico, Mexico
Site insights

Top conditions

Human Influenza (2 trials)

COVID-19 (2 trials)

Mucopolysaccharidoses (1 trial)

Leukemia (1 trial)

Dengue (1 trial)

Top treatments

Carfilzomib
Nusinersen
PF-07321332
LY3009104
Baricitinib
Pazufloxacin
Gatifloxacin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER)

The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronaviru...

Enrolling
Corona Virus Infection
Covid19
Drug: Baricitinib

The purpose of this study is to describe antibody persistence for each of the 4 dengue serotypes for up to 63 months after the first vaccination in t...

Active, not recruiting
Dengue Fever
Biological: Takeda's Dengue Tetravalent Vaccine (Live, Attenuated) (TDV)
Biological: Placebo
Status recently updated

The purpose of Phase 1b of this study is to:Asses the safety, tolerability and activity of carfilzomib, alone and in combination with induction chemo...

Enrolling
Active, not recruiting
Acute Lymphoblastic Leukemia (ALL)
Drug: Vincristine
Drug: Intrathecal (IT) Methotrexate

The primary objectives of this study are to examine the clinical efficacy of nusinersen administered intrathecally at higher doses to participants wi...

Active, not recruiting
Muscular Atrophy, Spinal
Drug: Nusinersen

Trial sponsors

Shire logo

Shire (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems